Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
Review of the FDA Draft Guidance: Considerations for Including Tissue Biopsies in Clinical Trials
Blog Posts
WCG Clinical | Insights
Advancing Clinical Trials with AI
Blog Posts
WCG Clinical | Insights
Leveraging Standardized Data to Streamline Site Feasibility
Blog Posts
WCG Clinical | Insights
The FDA’s Guidance on Electronic Records and Signatures: Key Takeaways
Blog Posts
WCG Clinical | Insights
The Role of AI in Regulatory Decision-Making for Drugs & Biologics: the FDA’s Latest Guidance
Blog Posts
WCG Clinical | Insights
Site Complexities and Start-up Barriers in Clinical Trials
Blog Posts
WCG Clinical | Insights
The FDA Accepts ICH E11A on Pediatric Extrapolation: How Does This Impact Your Pediatric Study?
Blog Posts
WCG Clinical | Insights
What Is a Biological Safety Cabinet? Do We Need One to Prepare Our Gene Therapy Product?
Blog Posts
WCG Clinical | Insights
Streamlining Recruitment & Retention with ClinSphere® Total Enrollment
Blog Posts
WCG Clinical | Insights